Solara announces closure of US FDA inspection at Puducherry facility
The Puducherry facility, dedicated to Ibuprofen and its derivatives, is equipped with advanced infrastructure to serve both domestic and international markets
The Puducherry facility, dedicated to Ibuprofen and its derivatives, is equipped with advanced infrastructure to serve both domestic and international markets
The association is intended to strengthen healthcare delivery standards, particularly in Oncology services, and enhance patient care outcomes
The agreement could rise to $900 million if key commercial milestones are met
The Danish biotech company confirmed the global study will begin in the second half of 2026
CPHI India from 23–25 November 2026 at Yashobhoomi (India International Convention and Expo Centre), while PMEC India from 24–26 November 2026 at India Expo Mart
Company confirms seized products were not from its authorised supply chain and urges patients to purchase medicines only through licensed pharmacies
New medical and wellness centre combines on-site care with telehealth to support industrial workforce and surrounding communities
Acquisition enhances integrated pharmacovigilance platform, combining AI, automation, and services to improve compliance, efficiency, and end-to-end clinical safety operations
Domestic sales increased 15.5%, supported by the relaunch of previously recalled products in the market
Subscribe To Our Newsletter & Stay Updated